Failure to Refer Residents With Serious Mental Illness for Level II PASRR Review
Summary
The facility failed to ensure residents with serious mental disorders were referred to the State Mental Health authority for a Level II PASRR review for two sampled residents. Resident #10 was admitted with diagnoses including unspecified schizophrenia, unspecified depression, unspecified anxiety disorder, and chronic post-traumatic stress disorder. The resident’s MDS showed antipsychotic, antianxiety, and antidepressant use, and the PASRR listed anxiety disorder, depressive disorder, schizophrenia, chronic PTSD, and unspecified insomnia based on documented history, family or legal representative report, and medications. A psychiatric note also documented ongoing anxiety symptoms, depersonalization, persistent worry, depression-related symptoms, and grief. Resident #10’s care plan addressed psychotropic medication use for depression, anxiety, and schizophrenia with delusions. During interview, the DON reviewed the PASRR and stated a Level II may not be necessary if the resident was not currently affected by mental illness. The traveling SSD similarly stated that a Level II PASRR was not automatically submitted solely because the resident had schizophrenia and that if symptoms were managed with medication and the resident was not exhibiting disruptive behaviors, a Level II was not needed. Resident #9’s record showed diagnoses including bipolar type schizoaffective disorder, unspecified schizophrenia, adjustment disorder with mixed disturbance of emotions and conduct, and unspecified recurrent major depressive disorder. The resident’s PASRRs listed anxiety disorder, bipolar disorder, depressive disorder, schizoaffective disorder, schizophrenia, cognitive communication disorder, adjustment disorder, psychosis, and later depressive disorder, schizoaffective disorder, schizophrenia, adjustment disorder with mixed disturbance of emotions and conduct, bipolar type schizoaffective disorder, and cognitive communication deficit. A psychiatry note documented continued treatment with Depakote and Risperdal and referenced prior behavioral health confirmation of hallucinations and delusions. Staff interviews showed the PASRR process was based on diagnoses, behaviors, and medications, but staff stated schizophrenia was not automatically considered a Level II trigger if the resident was stable and not displaying behaviors.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.